HashiCorp share price rises following report of antitrust investigation into IBM agreement

HashiCorp share price rises following report of antitrust investigation into IBM agreement



HashiCorp (Sanitary professional) saw a slight increase in its stock price after reports surfaced regarding the antitrust review of its acquisition by IBM (NYSE:IBM). The Department of Justice, known for scrutinizing IBM deals, did not raise any objections to HashiCorp’s sale for $6.4 billion, signaling a potential green light for the transaction to proceed. However, the Federal Trade Commission (FTC) did not have enough time to complete its review, prompting IBM to withdraw and resubmit its pre-merger notice in order to grant the FTC additional time for evaluation.

While the specific focus of the FTC’s investigation remains undisclosed, sources remain optimistic that a second request for information may be avoided. Recent reports from Capitol Forum also shed light on the FTC’s concerns regarding the potential impact of the acquisition on competition and innovation in cloud software and encryption tools. Questions have been raised regarding whether HashiCorp customers would have viable alternatives to the company’s products post-acquisition, with options such as OpenTofu and OpenBao being suggested as potential substitutes.

Following comments made by IBM regarding the deal’s progress during a gathering at Mizuho, HashiCorp’s stock experienced a 1.1% increase on June 12. IBM’s discussions at the event hinted at the possibility of the deal receiving antitrust approval, leading to speculation among traders. IBM’s initial agreement in late April to acquire HashiCorp for $35 per share in cash set the stage for the ongoing reviews by regulatory agencies.

As the acquisition continues to undergo scrutiny from regulatory bodies, including the DOJ and the FTC, the fate of the deal remains uncertain. While initial indications suggest that the DOJ may not pose significant obstacles to the transaction, the FTC’s ongoing evaluation raises questions about potential antitrust concerns and their impact on market competition. Despite these challenges, both IBM and HashiCorp remain hopeful that the deal will ultimately receive approval, allowing them to move forward with their plans for collaboration and growth in the cloud software and encryption sectors.

Article Source
https://seekingalpha.com/news/4118022-hashicorp-ticks-higher-amid-report-about-antitrust-probe-of-ibm-deal?source=content_type:react|first_level_url:market-news|section_asset:main